ReviewActa chirurgiae orthopaedicae et traumatologiae Cechoslovaca2025
[Revision Arthroplasty for Periprosthetic Femoral Fracture Complicated by Multidrug-Resistant Escherichia coli: Case Report and Minireview].
Review in Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Periprosthetic infections caused by multi-resistant bacteria are one of the most fearsome complications in current orthopedics. Despite using aseptic modern practices, the number of infectious complications caused by multidrug-resistant strains is rising worldwide. We present a case of a woman with a non-healing wound after hip arthroplasty revision surgery performed in Egypt for periprosthetic femoral fracture. Upon admission, 11 days after surgery, she presented with a purulent secretion from surgical wound and signs of sepsis. Carbapenem-resistant E. coli was proven from a wound swab. Two-stage revision with a 6-week-long interval of targeted parenteral antibiotic therapy was indicated. During explantation, excessive femoral bone loss after inadequately performed trauma revision surgery was discovered. After antibiotic hip spacer period, the patient underwent implantation of a cemented tumorous revision hip implant followed by 6 weeks of antibiotic therapy. The patient was discharged in more than satisfactory condition, being self-sufficient using French crutches. In follow-up visits during next 2 years, no relapse of carbapenem-resistant infection occurred. In patients hospitalized or operated in high-risk areas, epidemiological anamnesis is of great importance and the possibility of importing multi-resistant bacteria should be considered. Infections caused by these bacteria prolong therapy and increase the cost of treatment significantly. The combination of arthroplasty extraction and targeted antibiotic therapy is recommended to treat periprosthetic infections.
Indexed as
Identifiers
41503625What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.